Hence, ultimately, we chose a ceRNA network (lncRNA NEAT1-miRNA hsa-miR-1-3p-mRNA GNA12) associated with the development of TAO for further validation. The gene discussed is NEAT1; the disease is thromboangiitis obliterans.